Frazier Financial Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Frazier Financial Advisors, LLC
- $126 Billion
- Q2 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 1,644 shares of AMRX stock, worth $14,220. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,644
Previous 599
174.46%
Holding current value
$14,220
Previous $3.63 Million
187.6%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
187Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$189 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$121 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$107 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$92.7 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...